The RAPID-PE Study

Patients presenting with intermediate-high risk pulmonary embolism (PE) who are eligible for treatment using the Bashir Endovascular Catheter for mechanical thrombolysis. All subjects are followed (via telephone visits) for approximately 30 days. Safety and efficacy measured by monitoring major events.

In order to participate you must meet the following criteria:

• Present with a filling defect in at least one major lobar pulmonary artery as determined by CTA.
• Diagnosed with intermediate risk PE with an RV/LV diameter ratio ≥ 0.9 by CTA.

You will be excluded from the study if any of the following criteria apply to you:

• Have contraindication to systemic or therapeutic doses of anticoagulants.
• Have had major surgery ≤ 10 days prior to inclusion in the study.
• Have had pulmonary thrombectomy or administration of thrombolytic agents within the previous 4 days.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.